Skip to main content
MicroTech Medical (Hangzhou) Co., Ltd. logo

MicroTech Medical (Hangzhou) Co., Ltd. — Investor Relations & Filings

Ticker · 2235 HKEX Manufacturing
Open in API
Filings indexed 349 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2235

About MicroTech Medical (Hangzhou) Co., Ltd.

http://www.microtechmd.com

MicroTech Medical, established in 2011, specializes in comprehensive diabetes management solutions. The company researches, develops, and commercializes medical devices for both diabetes monitoring and treatment. Its product portfolio includes Continuous Glucose Monitoring Systems (CGMS), Blood Glucose Monitoring Systems (BGMS), and advanced treatment technologies. A key innovation is the independently developed patch insulin pump system, which incorporates an algorithm module for data analysis. MicroTech is committed to providing user-friendly devices and integrating monitoring and treatment through a developing cloud-based management platform.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Regulatory Filings
2026-05-04 English
Next Day Disclosure Return
Regulatory Filings
2026-04-30 English
Annual Report 2025
Regulatory Filings
2026-04-30 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a regulatory ‘Next Day Disclosure Return’ under Form FF305 filed by a listed issuer reporting detailed changes in issued shares, treasury shares, and on-market repurchases of its own stock. It includes sections on share repurchase transactions and disclosures required by the Hong Kong Stock Exchange listing rules. This clearly falls under ‘Transaction in Own Shares’ (POS) rather than an announcement of a new report or a general capital/financing update.
2026-04-29 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is the Hong Kong Exchange Next Day Disclosure Return (Form FF305) for changes in issued shares and treasury shares, including detailed repurchase report and treasury share transactions. It specifically reports on the company buying back its own shares, matching the definition of Transaction in Own Shares.
2026-04-28 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (Form FF305) under the Hong Kong Main Board/GEM rules detailing a change in issued shares and a share repurchase (treasury shares) by the issuer. It provides exact numbers of shares repurchased, repurchase prices, confirmation clauses, and compliance with listing rules. This is clearly a report of the company buying back its own shares (“transaction in own shares”). Therefore it falls under the “Transaction in Own Shares” category (POS).
2026-04-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.